litlas
Log inCreate account

Scott Kopetz

Active 2000–2026

316
Papers
51,914
Citations
111
h-index
301
i10-index

Citations

Citations per year for Scott Kopetz1990: 1 citations1991: 1 citations1992: 1 citations1993: 2 citations2001: 1 citations2002: 2 citations2003: 6 citations2004: 2 citations2005: 2 citations2007: 10 citations2008: 12 citations2009: 37 citations2010: 90 citations2011: 94 citations2012: 163 citations2013: 218 citations2014: 211 citations2015: 281 citations2016: 443 citations2017: 656 citations2018: 679 citations2019: 2,427 citations2020: 2,940 citations2021: 3,059 citations2022: 2,405 citations2023: 2,072 citations2024: 2,782 citations2025: 1,582 citations2026: 57 citations1994–2000: no citations, so these years are not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,300 citing papers, 23.3% of this breakdownChina: 3,532 citing papers, 15.5% of this breakdownItaly: 1,350 citing papers, 5.9% of this breakdownUnited Kingdom: 1,196 citing papers, 5.3% of this breakdownGermany: 1,018 citing papers, 4.5% of this breakdownFrance: 931 citing papers, 4.1% of this breakdownJapan: 813 citing papers, 3.6% of this breakdownSpain: 775 citing papers, 3.4% of this breakdownNetherlands: 678 citing papers, 3% of this breakdownCanada: 560 citing papers, 2.5% of this breakdownAustralia: 517 citing papers, 2.3% of this breakdownSouth Korea: 452 citing papers, 2% of this breakdown
0%23.3%Other 24.6%

Institutions

Fields

  • Medicine57%
  • Biochemistry, Genetics and Molecular Biology34.7%
  • Immunology and Microbiology4.1%
  • Computer Science0.9%
  • Engineering0.9%
  • Neuroscience0.5%
  • Other1.9%

Topics

  • Cancer Immunotherapy and Biomarkers6.9%
  • Cancer Genomics and Diagnostics6.4%
  • Colorectal Cancer Treatments and Studies6.4%
  • Genetic factors in colorectal cancer4.9%
  • Cancer Cells and Metastasis3.1%
  • Lung Cancer Treatments and Mutations2.2%
  • Other70.1%

Coauthors

All papers

Open in search
  1. The consensus molecular subtypes of colorectal cancer

    Authors: Justin Guinney, Rodrigo Dienstmann, Xin Wang, Aurélien de Reyniès, Andreas Schlicker, Charlotte Soneson, Laëtitia Marisa, Paul Roepman, Gift Nyamundanda, Paolo Angelino, Brian M. Bot, Jeffrey S. Morris, Iris Simón, Sarah Gerster, Evelyn Fessler, Felipe de Sousa e Melo, Edoardo Missiaglia, Hena R. Ramay, David Barras, Krisztián Homicskó, Dipen Maru, Ganiraju C. Manyam, Bradley M. Broom, Valérie Boige, Beatriz Pérez‐Villamil, Ted Laderas, Ramón Salazar, Joe W. Gray, Douglas Hanahan, Josep Tabernero, René Bernards, Stephen Friend, Pierre Laurent‐Puig, Jan Paul Medema, Anguraj Sadanandam, Lodewyk F.A. Wessels, Mauro Delorenzi, Scott Kopetz, Louis Vermeulen, Sabine Tejpar - Nature Medicine 2015 cited by 5,259

  2. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

    Authors: Michael J. Overman, Ray McDermott, Joseph L. Leach, Sara Lonardi, Heinz‐Josef Lenz, Michael A. Morse, Jayesh Desai, Andrew Hill, Michael D. Axelson, Rebecca A. Moss, Monica V. Goldberg, Z. Alexander Cao, Jean-Marie Ledeine, Gregory A. Maglinte, Scott Kopetz, Thierry André - The Lancet Oncology 2017 cited by 2,816

  3. Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

    Authors: Scott Kopetz, Axel Grothey, Rona Yaeger, Eric Van Cutsem, Jayesh Desai, Takayuki Yoshino, Harpreet Wasan, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod Kyrre Guren, Hendrik‐Tobias Arkenau, Pilar García‐Alfonso, Per Pfeiffer, Sergey Orlov, Sara Lonardi, Elena Élez, Tae-Won Kim, Jan H.M. Schellens, Christina Guo, Asha Krishnan, Jeroen Dekervel, Van K. Morris, Aitana Calvo Ferrandiz, Line Schmidt Tarpgaard, Michael Braun, Ashwin Gollerkeri, Christopher Hunt Keir, Kati Maharry, Michael D. Pickard, Janna Christy‐Bittel, Lisa Anderson, Victor Sandor, Josep Tabernero - New England Journal of Medicine 2019 cited by 1,465

  4. Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer

    Authors: Michael J. Overman, Sara Lonardi, Ka Yeung Mark Wong, Heinz‐Josef Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Magali Svrcek, Rebecca A. Moss, Jean-Marie Ledeine, Z. Alexander Cao, Shital Kamble, Scott Kopetz, Thierry André - Journal of Clinical Oncology 2018 cited by 2,070

  5. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

    Authors: Wenting Liao, Michael J. Overman, Adam T. Boutin, Xiaoying Shang, Di Zhao, Prasenjit Dey, Jiexi Li, Guocan Wang, Zhengdao Lan, Jun Li, Ming‐Jer Tang, Shan Jiang, Xingdi Ma, Peiwen Chen, Riham Katkhuda, Krittiya Korphaisarn, Deepavali Chakravarti, Andrew Chang, Denise J. Spring, Qing Chang, Jianhua Zhang, Dipen M. Maru, Dean Y. Maeda, John A. Zebala, Scott Kopetz, Yin Wang, Ronald A. DePinho - Cancer Cell 2019 cited by 610

  6. Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E–Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

    Authors: Josep Tabernero, Axel Grothey, Eric Van Cutsem, Rona Yaeger, Harpreet Wasan, Takayuki Yoshino, Jayesh Desai, Fortunato Ciardiello, Fotios Loupakis, Yong Sang Hong, Neeltje Steeghs, Tormod Kyrre Guren, Hendrik-Tobias Arkenau, Pilar García‐Alfonso, Elena Élez, Ashwin Gollerkeri, Kati Maharry, Janna Christy‐Bittel, Scott Kopetz - Journal of Clinical Oncology 2021 cited by 544

  7. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

    Authors: Rodrigo Dienstmann, Louis Vermeulen, Justin Guinney, Scott Kopetz, Sabine Tejpar, Josep Tabernero - Nature reviews. Cancer 2017 cited by 1,030

  8. Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial

    Authors: Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N Munster, John C Krauss, Gerald S Falchook, Sae-Won Han, Volker Heinemann, Kei Muro, John H Strickler, David S Hong, Crystal S Denlinger, Gustavo Girotto, Myung-Ah Lee, Haby Henary, Qui Tran, Joseph K Park, Gataree Ngarmchamnanrith, Hans Prenen, Timothy J Price - The Lancet Oncology 2021 cited by 288

  9. Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

    Authors: Jérôme Galon, Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell, Anne Berger, Christine Lagorce, Alessandro Lugli, Inti Zlobec, Arndt Hartmann, Carlo Bifulco, Irıs D. Nagtegaal, Richard Palmqvist, Giuseppe Masucci, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Michele Maio, Luigi Laghi, Fabio Grizzi, Martin Asslaber, Corrado D’Arrigo, Fernando Vidal‐Vanaclocha, Eva Závadová, Lotfi Chouchane, Pamela S. Ohashi, Sara Hafezi‐Bakhtiari, Bradly G. Wouters, Michael H. A. Roehrl, Linh N Nguyen, Yutaka Kawakami, Shoichi Hazama, Kiyotaka Okuno, Shuji Ogino, Peter Gibbs, Paul Waring, Noriyuki Sato, Toshihiko Torigoe, Kyogo Itoh, Prabhudas S. Patel, Shilin N. Shukla, Yili Wang, Scott Kopetz, Frank A. Sinicrope, Viorel Scripcariu, Paolo A. Ascierto, Francesco M. Marincola, Bernard A. Fox, Franck Pagès - The Journal of Pathology 2013 cited by 1,347

  10. Patient-derived micro-organospheres enable clinical precision oncology

    Authors: Shengli Ding, Carolyn Hsu, Zhaohui Wang, Naveen Natesh, Rosemary Millen, Marcos Negrete, Nicholas Giroux, Grecia O. Rivera, Anders B. Dohlman, Shree Bose, Tomer Rotstein, Kassandra V. Spiller, Athena Yeung, Zhiguo Sun, Chongming Jiang, Rui Xi, Benjamin Wilkin, Peggy M. Randon, Ian Williamson, Daniel Nelson, Daniel Delubac, Sehwa Oh, Gabrielle Rupprecht, James Isaacs, Jingquan Jia, Chao Chen, John Paul Shen, Scott Kopetz, Shannon J. McCall, Amber R. Smith, Nikolche Gjorevski, Antje‐Christine Walz, Scott Antonia, Estelle Marrer‐Berger, Hans Clevers, David S. Hsu, Xiling Shen - Cell stem cell 2022 cited by 209

  11. Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

    Authors: Thierry André, Sara Lonardi, Ka Yeung Mark Wong, H.J. Lenz, Fabio Gelsomino, Massimo Aglietta, Michael A. Morse, Eric Van Cutsem, Ray McDermott, Andrew Hill, Michael B. Sawyer, Alain Hendlisz, Bart Neyns, Sandzhar Abdullaev, Arteid Memaj, Ming Lei, Michael F. Dixon, Scott Kopetz, Michael J. Overman - Annals of Oncology 2022 cited by 253

  12. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma

    Authors: Sangeeta Goswami, Thomas Walle, Andrew Cornish, Sreyashi Basu, Swetha Anandhan, Irina Fernandez, Luis M. Vence, Jorge Blando, Hao Zhao, Shalini S. Yadav, Martina Ott, Ling Yuan Kong, Amy B. Heimberger, John de Groot, Boris Sepesi, Michael J. Overman, Scott Kopetz, James P. Allison, Dana Pe’er, Padmanee Sharma - Nature Medicine 2019 cited by 377

  13. KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

    Authors: Meagan B. Ryan, Oluwadara Coker, Alexey V. Sorokin, Katerina A. Fella, Haley Barnes, Edmond Wong, Preeti Kanikarla Marie, Fengqin Gao, Youyan Zhang, Lian Zhou, Scott Kopetz, Ryan B. Corcoran - Cell Reports 2022 cited by 156

  14. Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018

    Authors: Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav - JAMA Oncology 2019 cited by 569

  15. Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer Progression

    Authors: Wen‐Hao Hsu, Kyle A. LaBella, Yiyun Lin, Ping Xu, Rumi Lee, Cheng‐En Hsieh, Lei Yang, Ashley Zhou, Jonathan M. Blecher, Chang‐Jiun Wu, Kangyu Lin, Xiaoying Shang, Shan Jiang, Denise J. Spring, Yan Xia, Peiwen Chen, John Paul Shen, Scott Kopetz, Ronald A. DePinho - Cancer Discovery 2023 cited by 113

  16. Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors

    Authors: Kaysia Ludford, Won Jin Ho, Jane V. Thomas, Kanwal Raghav, M Murphy, Nicole D. Fleming, Michael S. Lee, Brandon G. Smaglo, Y. Nancy You, Matthew M. Tillman, Carlos Kamiya-Matsuoka, Selvi Thirumurthi, Craig Messick, Benny Johnson, Eduardo Vilar, Arvind Dasari, Sarah M. Shin, Alexei Hernandez, Xuan Yuan, Hongqui Yang, Wai Chin Foo, Wei Qiao, Dipen M. Maru, Scott Kopetz, Michael J. Overman - Journal of Clinical Oncology 2023 cited by 193

  17. Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)

    Authors: Scott Kopetz, Katherine A. Guthrie, Van K. Morris, Heinz‐Josef Lenz, Anthony M. Magliocco, Dipen M. Maru, Yibing Yan, Richard B. Lanman, Ganiraju C. Manyam, David S. Hong, Alexey V. Sorokin, Chloé E. Atreya, Luis A. Díaz, Carmen J. Allegra, Kanwal Raghav, Stephen E Wang, Christopher H. Lieu, Shannon McDonough, Philip A. Philip, Howard S. Höchster - Journal of Clinical Oncology 2020 cited by 391

  18. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

    Authors: Arvind Dasari, Van K. Morris, Carmen J. Allegra, Chloé E. Atreya, Al B. Benson, Patrick M. Boland, Ki Yong Chung, Mehmet Sitki Copur, Ryan B. Corcoran, Dustin A. Deming, Andrea Dwyer, Maximilian Diehn, Cathy Eng, Thomas J. George, Marc J. Gollub, Rachel Goodwin, Stanley R. Hamilton, Jaclyn F. Hechtman, Howard S. Höchster, Theodore S. Hong, Federico Innocenti, Atif Iqbal, Samuel A. Jacobs, Hagen F. Kennecke, James J. Lee, Christopher H. Lieu, Heinz‐Josef Lenz, O. Wolf Lindwasser, Clara Montagut, Bruno C. Odisio, Fang‐Shu Ou, Laura Porter, Kanwal Raghav, Deborah Schrag, Aaron J. Scott, Qian Shi, John H. Strickler, Alan P. Venook, Rona Yaeger, Greg Yothers, Y. Nancy You, Jason A. Zell, Scott Kopetz - Nature Reviews Clinical Oncology 2020 cited by 365

  19. How liquid biopsies can change clinical practice in oncology

    Authors: Giulia Siravegna, Benedetta Mussolin, Tiziana Venesio, Silvia Marsoni, Joan Seoane, Caroline Dive, Nickolas Papadopoulos, Scott Kopetz, Ryan B. Corcoran, Lillian L. Siu, Alberto Bardelli - Annals of Oncology 2019 cited by 353

  20. Clinical and molecular characterization of early‐onset colorectal cancer

    Authors: Alexandra N. Willauer, Yusha Liu, Allan Andresson Lima Pereira, Michael Lam, Jeffrey S. Morris, Kanwal Raghav, Van K. Morris, David G. Menter, Russell R. Broaddus, Funda Meric‐Bernstam, Andrea Hayes‐Jordan, Winston W. Huh, Michael J. Overman, Scott Kopetz, Jonathan M. Loree - Cancer 2019 cited by 365

  21. Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

    Authors: Richard B. Lanman, Stefanie Mortimer, Oliver A. Zill, Dragan Sebisanovic, René López, Sibel Blau, Eric A. Collisson, Stephen G. Divers, Dave S.�B. Hoon, Scott Kopetz, Jeeyun Lee, Petros Nikolinakos, Arthur M. Baca, Bahram G. Kermani, Helmy Eltoukhy, AmirAli Talasaz - PLoS ONE 2015 cited by 713

  22. Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRAS G12C-Mutated Metastatic Colorectal Cancer

    Authors: Rona Yaeger, Nataliya V. Uboha, Meredith S. Pelster, Tanios Bekaii‐Saab, Minal Barve, Joel Saltzman, Joshua K. Sabari, Julio A. Peguero, Andrew Scott Paulson, Pasi A. Jänne, Marcia Cruz‐Correa, Kenna Anderes, Karen Velastegui, Xiaohong Yan, Hirak Der‐Torossian, Samuel J. Klempner, Scott Kopetz - Cancer Discovery 2024 cited by 117

  23. Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF -Mutated Colorectal Cancer

    Authors: Scott Kopetz, Jayesh Desai, Emily Chan, J. Randolph Hecht, Peter J. O’Dwyer, Dipen M. Maru, Van K. Morris, Filip Jankú, Arvind Dasari, Woonbok Chung, Jean‐Pierre J. Issa, Peter Gibbs, Brian P. James, Garth Powis, K. B. Nolop, Suman Bhattacharya, Leonard B. Saltz - Journal of Clinical Oncology 2015 cited by 693

  24. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

    Authors: Takayuki Yoshino, Dirk Arnold, Hiroya Taniguchi, George Pentheroudakis, Kentaro Yamazaki, Rui‐Hua Xu, Tae‐Woo Kim, Muhammad Ismail, Iain Tan, Kun‐Huei Yeh, Axel Grothey, S. Zhang, Joong Bae Ahn, M.Y. Mastura, Dawn Q. Chong, Liqun Chen, Scott Kopetz, Takako Eguchi-Nakajima, Hiromichi Ebi, Atsushi Ohtsu, Andrés Cervantes, Kei Muro, Josep Tabernero, Hironobu Minami, Fortunato Ciardiello, Jean‐Yves Douillard - Annals of Oncology 2017 cited by 592